Acute Lower Back Problems in Adults - Overview
1. Overview
Purpose and Rationale
There are four principal reasons acute low back problems were
selected as a subject for guideline development. One reason is
their prevalence. Most people report low back problems at some
time in their lives, and national statistics indicate a general
yearly prevalence in the U.S. population of 1520 percent.
[1]<http://text.nlm.nih.gov>
Among workingage people surveyed, 50 percent admit to back
symptoms each year. [2]<http://text.nlm.nih.gov>,
[3]<http://text.nlm.nih.gov>
Back symptoms, in fact, are the most common cause of disability
for persons under age 45. [4]<http://text.nlm.nih.gov>
At any given time, about 1 percent of the U.S. population is
chronically disabled because of back problems, and another 1
percent temporarily disabled. [1]<http://text.nlm.nih.gov>
A second reason for a guideline
on assessment and treatment of acute low back problems is cost.
Low back problems are expensive. Their total costs to society
are difficult to calculate, but evidence indicates that both
the economic and psychosocial costs are substantial. Low back
problems are the second most common symptomatic reason expressed
by patients for office visits to primary care physicians. [5]<http://text.nlm.nih.gov>
They are the most common reason for office visits to orthopedic
surgeons, neurosurgeons, and occupational medicine physicians.
They rank third among the reasons for surgical procedures.
Moreover, although medical costs are high, loss of time from
work as well as the disability payments for workrelated
low back problems can together cost up to three times as much
as medical treatment. [6]<http://text.nlm.nih.gov>
About 2 percent of the U.S. work force has compensable back problems
each year. [7]<http://text.nlm.nih.gov>
Various estimates of the total annual societal cost of back pain
in the United States range from $20 to $50 billion. [8]<http://text.nlm.nih.gov>
Nonmonetary costs of low back problems can also be substantial.
The inability to function normally at work and in other daily
activities has an impact on both patients and their families.
A third important reason for
this guideline is the increasing evidence that many patients
with activity intolerance due to low back symptoms may be receiving
care that is inappropriate or at least less than optimal. Rates
for hospitalization and surgery for low back problems vary substantially
among regions of the United States as well as among small areas
within states. [9]<http://text.nlm.nih.gov>[11]
<http://text.nlm.nih.gov>
Marked regional variations also occur in the use of diagnostic
tests for assessing low back problems. [9]<http://text.nlm.nih.gov>
These variations imply a lack of consensus about appropriate
assessment and treatment of low back problems, suggesting that
some patients may be receiving inappropriate or suboptimal care.
In addition, some patients appear to be more disabled after treatment
than before, another potential indicator of suboptimal care.
Perhaps the most obvious examples involve surgery. Despite an
extensive medical literature on failed back surgery and evidence
that repeat surgical procedures for low back problems rarely
lead to improved outcome, there are documented examples of patients
who have had as many as 20 spine operations. [9]<http://text.nlm.nih.gov>However,
surgery is not the only treatment that can lead to increased
disability. Common treatment methods such as extended bed rest
or extended use of highdose opioids can prolong symptoms
and further debilitate patients.
A fourth reason for the guideline
is a growing body of research on low back problems, allowing
a systematic evaluation of commonly used assessment and treatment
methods. Although the existing literature has shortcomings, there
is sufficient scientific evidence for a number of conclusions
about the efficacy and safety of current assessment and treatment
methods.
Bigos S, Bowyer O, Braen G,
et al. Acute Low Back Problems in Adults.
Clinical Practice Guideline No. 14. AHCPR Publication No. 950642.
Rockville, MD: Agency for Health Care Policy and Research, Public
Health
Service, U.S. Department of Health and Human Services. December
1994.









